Crossmark

Neoadjuvant chemotherapy with or without PD-1/PD-L1 inhibitors in resectable esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s12876-025-04030-7

Published Online: 2025-05-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Ye

Chen, Jie

Yu, Fenglian

Zhang, Wenxiong

Zhong, Yingmei
License Information

Text and Data Mining valid from 2025-05-29

Version of Record valid from 2025-05-29
More Information

Article History

Received: 18 March 2025

Accepted: 23 May 2025

First Online: 29 May 2025

Declarations

:

: As a systematic review and meta-analysis, our study did not require any human participation and, referral to our ethics committee.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below